HARVARD BIOSCIENCE INC — Director's Dealing 2011

Jun 7, 2011

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: HARVARD BIOSCIENCE INC (HBIO)
CIK: 0001123494
Period of Report: 2011-06-02

Reporting Person: McNaughton Thomas (Chief Financial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2011-06-02	Common Stock	A	25000	—	Acquired	85810	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2011-06-02	Stock option (right to buy)	$5.64	A	50000	Acquired	2021-06-02	Common Stock, par value $0.01 per share (50000)	Direct

Footnotes

F1: Includes (a) a deferred stock award of 50,100 restricted stock units which vest in equal installments on January 1, 2012; January 1, 2013 and January 1, 2014; (b) a deferred stock award of 25,000 restricted stock units which vest in equal installments on January 1, 2012; January 1, 2013; January 1, 2014; and January 1, 2015; and (c) 10,710 shares of common stock held by Mr. McNaughton.

F2: The options vest in four equal installments on the first four anniversaries on January 1, 2011.